{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-028605","form_type":"8-K","ticker":"FOXO","cik":"0001812360","company_name":"FOXO TECHNOLOGIES INC.","filed_at":"2025-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.552730+00:00","generated_at":"2026-05-16T12:37:30.955113+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"FOXO Technologies amends preferred stock terms and increases authorized shares via majority stockholder consent","bullets":["Filed amendments to Series B and C Preferred Stock, revising conversion price to higher of $0.0001 or 90% of 5-day VWAP and removing mandatory conversion.","Majority stockholder Rennova Health (controlled by CEO) holding ~98.6% voting rights approved increase of Common Stock from 2.5B to 10B shares and Preferred from 10M to 20M shares.","Re-elected directors Seamus Lagan, Trevor Langley, Francis Colt deWolf III, Bret Barnes, and Mark White to board.","Ratified appointment of Kreit & Chiu CPA LLP as independent auditor for fiscal year 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-028605","json":"https://secwatch.observer/filing/0001493152-25-028605.json","markdown":"https://secwatch.observer/filing/0001493152-25-028605.md","text":"https://secwatch.observer/filing/0001493152-25-028605.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812360/000149315225028605/0001493152-25-028605-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812360/000149315225028605/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-16T12:37:30.955113+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"222a6089a679399d0f84b3ad0bbb50489223c13d","claim":"FOXO TECHNOLOGIES INC.: Filed Amended Designations for Series B and Series C Preferred Stock, revising conversion price and removing mandatory conversion provision, and exempting dividends on Series E Preferred Stock from certain restrictions (effective 2025-12-16).","evidence_excerpt":"On December 16, 2025, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), filed amendments to the Company’s Certificate of Incorporation (the “ Certificate of Incorporation ”), in the form of Amended and Restated Certificates of Designation (the “ Amended Designations ”) of the Company’s previously designated “Series B Cumulative Convertible Redeemable Preferred Stock” (the “ Series B Preferred Stock ”) and the Company’s previously designated “Series C Cumulative Convertible Redeemable Preferred Stock” (the “ Series C Preferred Stock ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812360/000149315225028605/0001493152-25-028605-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-12-16"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}